Global Survey Reveals People Want More Investment And Faster Access To New Cancer Treatments
INDIANAPOLIS, Jan. 28, 2013 /PRNewswire/ -- PACE ( Patient Access to Cancer care Excellence), a Lilly Oncology initiative, announces the following webcast:
What: PACE Cancer Perception Index webcastWhen: Wednesday, January 30, 2013, from 11:00 a.m. to 12:00 p.m. ESTWhere: http://www.videonewswire.com/event.asp?id=91886 How: Live over the Internet; simply register via the address above
- The public's cancer IQ is rising, but myths persist. They recognize cancer progress, but want faster results. They have a high interest in clinical trial participation and sharing results. Still, tough questions and concerns remain, such as how much money should be spent on cancer treatment for an extra year of life and who should pay for it.
- This survey of 4,341 individuals in the United States, France, Germany, Italy, Japan and the United Kingdom was commissioned by Lilly Oncology and conducted by GfK, one of the world's leading research companies.
- PACE, a Lilly Oncology initiative, is an emerging global network of collaborations between industry and other sectors intended to improve public policies that determine the accessibility, speed and value of progress against cancer.
SOURCE Lilly Oncology
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
